Keep your eyes glued on these nine stocks today!

TCS: The company has been named a leader in IDC MarketScape for Supply Chain Oracle Ecosystem Services.   

Bal Pharma: The company announced the launch of Favipiravir formulation into Indian market under the brand name BALflu. It has been approved by DCGI for emergency use of COVID-19 treatment with the recommended dosage of 1,800 mg on the first day, followed by 800 mg from day 2 to 14.  

GMM Pfaudler: The company has commenced manufacturing operations at its facility at Vatva near Ahmedabad on May 24, 2021. GMMP had acquired the assets [factory land, building, plant & machinery, office equipment, etc] owned by HDO Technologies Limited (in liquidation) through an e-auction in March 2021.  

EPL: The company informed that it has been selected as a partner by one of the world’s leading FMCG companies, GSK Consumer Healthcare (GSKCH), for achieving 100 per cent sustainability in the oral care segment. In accordance with the partnership, EPL will be supplying their APR approved 100 per cent recyclable & fully sustainable Platina tubes, for the toothpaste range of GSKCH. EPL’s Platina tube with HDPE closure is the world’s first fully sustainable and completely recyclable tube accredited by APR.  

CG Power & Industrial Solutions: The company has informed that the e-listing and admission to trading of the global depository receipts (GDRs), on London Stock Exchange (LSE) stands cancelled and the GDRs have been delisted from LSE w.e.f. May 24, 2021 (Monday).   

ADF Foods: During the year, the company set up a manufacturing facility in Surat, (Gujarat) on lease. The facility is expected to increase the production capacity by 1,950 MTPA. The Capex of this project was Rs 2 crore. The facility was established in response to the increased demand for the company’s core products- frozen bread, snacks along with ready-to-eat products. The facility started commercial production of frozen bread w.e.f. March 25, 2021. Besides, the company had recently acquired a land parcel of around 7 acres in Gujarat for a greenfield expansion. A Capex outlay of Rs 60 crore has been announced for Phase 1, which would see an increase in capacity of frozen foods, ready-to-eat, and condiment categories. This expansion would bring a potential 10,000 MTPA, in addition to the overall manufacturing capacity.   

India Cements: The net plant realisation for the year was up by 12 per cent when compared with the previous year.   

Cupid: The company has started its production activities in a factory situated at Sinnar (Nasik).   

Panecea Biotec: The company announced the launch of Russian Sputnik V vaccine production against Coronavirus in association with Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund). The production would take place at Panacea Biotec's facilities at Baddi (Himachal Pradesh).